Send a Tweet
Most Popular Choices
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Tell A Friend Printer Friendly Page Save As Favorite View Favorites
Sci Tech

New cancer therapy: Low Iron + High Dose Vitamin C (Bill Sardi)

Quicklink Submitted By   Follow Me on Twitter     Message Josh Mitteldorf     Permalink    (# of views)   No comments

Related Topic(s): , Add Tags

View Ratings | Rate It

Become a Fan
  (41 fans)

A breakthrough in understanding of vit C therapy for cancer. Researchers in Japan report extracellular iron decomposes hydrogen peroxide generated by vitamin C. The inhibition of cancer cell growth via vitC is blocked by the presence of iron. [Scientific Reports 2018] This was demonstrated in leukemia cells in a lab dish.  

With this new understanding, researchers employed iron-binding molecules prior to vitamin C treatment with demonstrable anti-cancer effects.  An iron-chelating drug, or donation of blood to reduce iron load, or a low iron diet (avoidance of red meat) increased the cell-killing effect of vitamin C. A reduction of iron combined with vitamin C infusions worked synergistically to the point where detection and invasion by tumor cells was completely eliminated. 

(Image by Unknown Owner)   Details   DMCA

Read the rest of the story HERE:



- Advertisement -

View Ratings | Rate It

Josh Mitteldorf, a senior editor at OpEdNews, blogs on aging at Read how to stay young at
Educated to be an astrophysicist, he has branched out from there to mathematical (more...)

Josh Mitteldorf Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines
Related Topic(s): , Add Tags
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
   (Opens new browser window)


The time limit for entering new comments on this quicklink has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

No comments